The United States spends twice as much per capita on prescription drugs as other developed countries, and most Americans are concerned about rising drug prices. U.S. net spending on pharmaceuticals now exceeds $450 billion annually. And these mounting costs, especially in Medicaid, have placed an increased burden on state budgets.
On Tuesday, July 10, The Pew Charitable Trusts hosted an event exploring the latest steps states are taking to address rising drug costs as well as possible strategies to tackle spending in the future.
During the event, get insights, statistics, and commentary—and join the conversation—by following #PewRxTalk on Twitter with @PewHealth.
State Senator Ronald Caldwell (R-AR)
State Senator Yvanna Cancela (D-NV)
Kelly Coates, associate vice president, clinical support services, University of Texas Medical Branch at Galveston
Allan Coukell, senior director, health programs, The Pew Charitable Trusts
Sean Dickson, officer, drug spending research initiative, The Pew Charitable Trusts
Jane Horvath, senior policy fellow, National Academy for State Health Policy
Mark Miller, vice president, health care, Laura and John Arnold Foundation
Erin Mershon, senior Washington correspondent, STAT (moderator)
John O'Brien, advisor to the Secretary and Deputy Assistant Secretary for Health Policy, U.S. Department of Health & Human Services
Hemi Tewarson, director, Center for Best Practices’ Health Division, National Governors Association